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We report here on the use of a prototype matrix-assisted
laser desorption/ionization (MALDI)-triple quadrupole
mass spectrometer for quantitative analysis of six anti-
retroviral drugs in lysates of peripheral blood mono-
nuclear cells (PBMC). Of the five investigated MALDI
matrixes, 2,5-dihydroxybenzoic acid (DHB) and the novel
7-hydroxy-4-(trifluoromethyl)coumarin (HFMC) showed
the broadest application ranges for the antiretroviral
drugs. For DHB, the mean relative errors ranged from
8.3 (ritonavir) to 4.3% (saquinavir). The mean precisions
(CV) ranged from 17.3 (nevirapine) to 10.8% (saquinavir).
The obtained lower limits of quantitation (LLOQ) readily
allow clinical applications using just 1 million PBMC from
HIV-infected patients under therapy. The new matrix
HFMC was used for quantitative analysis of the HIV
protease inhibitor indinavir using a stainless steel target
plate as well as a target plate with a novel, strongly
hydrophobic fluoropolymer coating. Using the coated
target plate, the mean relative error improved from 10.1
to 4.6%, the mean precision from 33.9 to 9.9% CV, and
the LLOQ from 16 to 1 fmol. In addition, the measure-
ment time for one spot went down from 6 to only 2.5 s.
Matrix-assisted laser desorption/ionization (MALDI) and elec-
trospray ionization (ESI) are extensively used as ionization
techniques for mass spectrometric analysis of biological samples.
For qualitative and quantitative analysis of compounds such as
pharmaceutical drugs, with molecular masses below 1000 Da, ESI
mass spectrometry is usually preferred over MALDI, because
analysis of small molecules with MALDI is often hampered by
matrix-derived chemical noise in the low m/z range. MALDI,
however, does offer important advantages over ESI, namely, the
much higher sample throughput and its insensitivity to ion
suppression.1,2 In addition, samples can be conveniently stored
on the target plates for future (re)analysis.3
Various approaches have been described to overcome the
problem of matrix-derived chemical noise, including carefully
optimized matrix-to-analyte ratios,4 the use of specialized addi-
tives,5 the use of ionic liquid matrixes6 or inorganic matrixes,7,8
or the application of high molecular weight matrixes.9–13 The
interfering noise can also conveniently be circumvented by using
tandem mass spectrometry (MS/MS). In the selected reaction
monitoring mode (SRM) of a triple quadrupole mass spectrometer,
interfering isobaric matrix ions are removed by monitoring only
compound-specific precursor/product ion transitions.2
Quantitative analysis of small molecules using MALDI mass
spectrometry is further complicated by poor reproducibilities of
ion signals from heterogeneous crystal layers. The precisions can
be improved, however, by using optimized cocrystallization
techniques for sample and matrix, for example, with prestructured
* To whom correspondence should be addressed. Tel. +44 1223 43 7550.
Fax +44 1223 43 7515. E-mail: Dietrich.Volmer@mrc-hnr.cam.ac.uk.
† Department of Neurology, Laboratory of Neuro-Oncology and Clinical &
Cancer Proteomics, Erasmus MC.
‡ Department of Paediatrics, Division of Paediatric Infectious Diseases &
Immunology, Erasmus MC-Sophia.
§ Department of Virology, Erasmus MC.
| UMC St. Radboud.
⊥ Medical Research Council.
(1) Volmer, D. A.; Sleno, L.; Bateman, K.; Sturino, C.; Oballa, R.; Mauriala, T.;
Corr, J. Anal. Chem. 2007, 79, 9000–9006.
(2) Yang, Y.; Zhang, S.; Howe, K.; Wilson, D. B.; Moser, F.; Irwin, D.;
Thannhauser, T. W. J. Biomol. Techmol. 2007, 18, 226–237.
(3) Dekker, L. J.; Burgers, P. C.; Guzel, C.; Luider, T. M. J. Chromatogr., B:
Anal. Technol. Biomed. Life Sci. 2007, 847, 62–64.
(4) McCombie, G.; Knochenmuss, R. Anal. Chem. 2004, 76, 4990–4997.
(5) Guo, Z.; Zhang, Q.; Zou, H.; Guo, B.; Ni, J. Anal. Chem. 2002, 74, 1637–
1641.
(6) Tholey, A.; Heinzle, E. Anal. Bioanal. Chem. 2006, 386, 24–37.
(7) Wei, J.; Buriak, J. M.; Siuzdak, G. Nature 1999, 399, 243–246.
(8) Kang, M. J.; Pyun, J. C.; Lee, J. C.; Choi, Y. J.; Park, J. H.; Park, J. G.; Lee,
J. G.; Choi, H. J. Rapid Commun. Mass Spectrom. 2005, 19, 3166–3170.
(9) Ayorinde, F. O.; Eribo, B. E.; Johnson, J. H., Jr.; Elhilo, E. Rapid Commun.
Mass Spectrom. 1999, 13, 1124–1128.
(10) Chen, Y. T.; Ling, Y. C. J. Mass Spectrom. 2002, 37, 716–730.
(11) Ling, Y. C.; Lin, L.; Chen, Y. T. Rapid Commun. Mass Spectrom. 1998, 12,
317–327.
(12) van Kampen, J. J.; Burgers, P. C.; de Groot, R.; Luider, T. M. Anal. Chem.
2006, 78, 5403–5411.
(13) van Kampen, J. J.; Verschuren, E. J.; Burgers, P. C.; Luider, T. M.; de Groot,
R.; Osterhaus, A. D.; Gruters, R. A. J. Chromatogr. B: Anal. Technol. Biomed.
Life Sci. 2007, 847, 38–44.
Anal. Chem. 2008, 80, 4969–4975
10.1021/ac800218a CCC: $40.75  2008 American Chemical Society 4969Analytical Chemistry, Vol. 80, No. 13, July 1, 2008
Published on Web 06/06/2008
target plates,14 fast evaporation protocols,15 and sophisticated
sample spotting devices.16 In addition, well-matched analytes and
internal standards as well as a sufficient number of repeat
measurements for signal averaging lead to significantly better
precision values, resulting in the successful development of several
quantitative drug assays using MALDI-TOF,12,13,17,18 MALDI-
qTOF,19,20 MALDI-FTICR, and MALDI-triple quadrupole19,21–27
mass spectrometry.
In this study, we have explored the feasibility of using a
prototype MALDI-triple quadrupole mass spectrometer for rapid
quantitative analysis of HIV protease inhibitors and a non-
nucleoside reverse transcriptase inhibitor in lysates of peripheral
blood mononuclear cells (PBMC).
EXPERIMENTAL SECTION
Chemicals. 7-Hydroxy-4-(trifluoromethyl)coumarin (HFMC),
2,5-dihydroxybenzoic acid (DHB), 3,5-dimethoxy-4-hydroxycin-
namic acid (sinapinic acid; SA), 3-hydroxypicolinic acid (HPA),
and R-cyano-4-hydroxycinnamic acid (HCCA) were obtained from
Sigma-Aldrich. The investigated drug compounds were kindly
(14) Schuerenberg, M.; Luebbert, C.; Eickhoff, H.; Kalkum, M.; Lehrach, H.;
Nordhoff, E. Anal. Chem. 2000, 72, 3436–3442.
(15) Vorm, O.; Roepstorff, P.; Mann, M. Anal. Chem. 1994, 66, 3281–3287.
(16) Hanton, S. D.; Hyder, I. Z.; Stets, J. R.; Owens, K. G.; Blair, W. R.; Guttman,
C. M.; Giuseppetti, A. A. J. Am. Soc. Mass Spectrom. 2004, 15, 168–179.
(17) Duncan, M. W.; Matanovic, G.; Cerpa-Poljak, A. Rapid Commun. Mass
Spectrom. 1993, 7, 1090–1094.
(18) Rideout, D.; Bustamante, A.; Siuzdak, G. Proc. Natl. Acad. Sci. U. S. A.
1993, 90, 10226–10229.
(19) Hatsis, P.; Brombacher, S.; Corr, J.; Kovarik, P.; Volmer, D. A. Rapid
Commun. Mass Spectrom. 2003, 17, 2303–2309.
(20) Notari, S.; Mancone, C.; Tripodi, M.; Narciso, P.; Fasano, M.; Ascenzi, P.
J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2006, 833, 109–116.
(21) Corr, J. J.; Kovarik, P.; Schneider, B. B.; Hendrikse, J.; Loboda, A.; Covey,
T. R. J. Am. Soc. Mass Spectrom. 2006, 17, 1129–1141.
(22) Gobey, J.; Cole, M.; Janiszewski, J.; Covey, T.; Chau, T.; Kovarik, P.; Corr,
J. Anal. Chem. 2005, 77, 5643–5654.
(23) Kovarik, P.; Grivet, C.; Bourgogne, E.; Hopfgartner, G. Rapid Commun.
Mass Spectrom. 2007, 21, 911–919.
(24) Signor, L.; Varesio, E.; Staack, R. F.; Starke, V.; Richter, W. F.; Hopfgartner,
G. J. Mass Spectrom. 2007, 42, 900–909.
(25) Sleno, L.; Volmer, D. A. Rapid Commun. Mass Spectrom. 2006, 20, 1517–
1524.
(26) Sleno, L.; Volmer, D. A. Rapid Commun. Mass Spectrom. 2005, 19, 1928–
1936.
(27) Sleno, L.; Volmer, D. A. Anal. Chem. 2005, 77, 1509–1517.
Figure 1. Comparison of signal intensities for HIV-1 protease inhibitors using various MALDI matrixes in combination with stainless steel
target plates. Seven protease inhibitors were spiked in a lysate of 1 × 106 PBMC and analyzed using various matrixes. The amount of protease
inhibitor per spot was 5 pmol. Reported are the mean areas and standard deviations of the SRM traces for a single spot (the areas for saquinavir
were divided by 10).
Table 1. Quantitative Analysis of Antiretroviral Drugs
in PBMC Lysate Using MALDI-QqQa
compound
LLOQ
(pmol)
ULOQ
(pmol)
precision
(% CV)
accuracy, RE
(% deviation) R2
nelfinavir 0.064 16 11.9 (3.2) 7.4 (4.4) 0.9998
indinavir 0.004 16 12.0 (6.8) 5.0 (3.6) 0.9999
saquinavir 0.016 4 10.8 (3.2) 4.3 (3.4) 0.9985
ritonavir 0.064 16 14.1 (8.3) 8.3 (6.2) 0.9975
lopinavir 0.064 16 12.9 (4.6) 6.7 (4.4) 0.9953
nevirapine 0.016 16 17.3 (3.8) 7.4 (4.5) 0.9999
a LLOQ, lower limit of quantitation in picomole per spot on the target
plate. ULOQ, upper limit of quantification in picomole per spot on the
target plate. Reported are the average precisions and accuracies (%
relative error, RE) for data sets A and B. R2 ) regression coefficient
of the 1/x weighed linear curve when data sets A and B were combined.
Standard deviations are reported in parentheses. All experimental data
in the table were obtained using DHB as maxtrix compound on an
uncoated stainless steel target.
Figure 2. 7-Hydroxy-4(trifluoromethyl)coumarin (HFMC).
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donated by the following companies: lopinavir and ritonavir, Abbott
Laboratories (Illinois, IL); saquinavir, F. Hoffmann-La Roche
(Basel, Switzerland); nelfinavir, Pfizer (Groton, CT); indinavir
Merck (Rahway, NJ); nevirapine and tipranavir, Boehringer
Ingelheim (Ingelheim am Rhein, Germany); amprenavir, Glaxo-
SmithKline (Middlesex, United Kingdom). Carbamazepine was
purchased from Sigma-Aldrich. The proprietary PFC1601V fluo-
ropolymer solution was obtained from Cytonix Corp. (Beltsville,
MD). Eye protection and gloves should be worn when handling
the fluoropolymer solution; there are no acute and chronic hazards
to be expected for this product and no carcinogenic properties
are known to be present (Material safety data sheet, Cytonix
Corp.).
Mass Spectrometry. An API 3000 MALDI-triple quadrupole
mass spectrometer (MDS Analytical Technologies, Concord, ON,
Canada) equipped with a prototype 1000-Hz Nd:YAG laser (355
nm) (PowerChip NanoLaser, JDS Uniphase, San Jose´, CA) MALDI
source was operated in the positive ion mode. The pressure in
the MALDI source was ∼5 mTorr. During laser firing, the target
plate was moved horizontally at a constant speed (∼0.06 cm/s)
and the SRM traces of the analyte(s) and internal standard(s) were
recorded (dwell time, 10 ms each). Analyst software version 1.1
(MDS Analytical Technologies) was used for data acquisition.
Sample Preparation. Peripheral blood mononuclear cells
(PBMC) were isolated from a buffy coat (Sanquin, Rotterdam,
The Netherlands) using a standard Ficoll density gradient. PBMC
pellets were lysed in 100% methanol overnight at 5 °C (100 µL of
MeOH per 1 × 106 PBMC). The lysed PBMC were spun down at
14 000 rpm for 5 min. Supernatants of 1 × 106 PBMC were
collected in 1.5-mL vials, and 400 µL of water was added to each
Figure 3. Droplets of 10 µL of DHB solution in various solvents spotted on a fluoropolymer-coated MALDI target. Upper row: left, DHB in
water; middle, DHB in ACN/water (1:1, v/v); right, DHB in MeOH/water (1:1, v/v). Lower row: left, DHB in CAN; middle, DHB in MeOH; right,
DHB in acetone.
Figure 4. HFMC matrix spotted on to a stainless steel target plate and a fluoropolymer-coated target plate. Left: 1 µL of HFMC matrix spotted
on to a stainless steel target plate (10 mg/mL in ACN/H2O (1:1, v/v)). Right: 10 µL of HFMC matrix spotted on to a fluoropolymer-coated target
plate (1 mg/mL in 100% acetonitrile). The dashed line represents the actual width of the laser beam (diameter, ∼110 µm). The etched circle is
∼3.5 mm wide.
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vial. Subsequently, the supernatants were cleaned using 96-well
solid-phase extraction (SPE) plates (Oasis HLB µelution plate,
Waters). Methanol and water (200 µL each) were drawn through
each well using a vacuum manifold according to the manufactur-
er’s protocol. Subsequently, the samples were loaded onto the
SPE plate and washed twice with methanol/water (1:4 v/v).
Finally, the samples were eluted from the plate with 100 µL of
methanol. Drug standards were added to the eluates and were
subsequently dried using a SpeedVac (Savant).
On the day of analysis, the dried samples were reconstituted
in 10 µL of matrix solution and replicates of 1 µL were spotted
onto 10 × 10 stainless steel target plates (Perseptive Biosystems,
Framingham, MA). For hydrophobically coated target plates, the
dried samples were reconstituted in 100 µL of matrix solution and
replicates of 10 µL were applied.
The following matrixes were used: 4 mg/mL HCCA, 50 mg/
mL DHB, 10 mg/mL HFMC, 50 mg/mL HPA, and 4 mg/mL SA.
All matrixes were dissolved in acetonitrile/water/formic acid (500:
500:1; v/v/v). For the HFMC matrix in combination with the
hydrophobic target plate, 1 mg/mL HFMC in acetonitrile/formic
acid (200:1; v/v) was used.
Scanning Electron Microscope (SEM). SEM photos were
obtained on a Hitachi S-3000N SEM (Hitachi Science Systems,
Hitachinaka, Japan). Various levels of magnification were used at
2.00-kV electron energy. Spot areas were determined using
SimplePCI software (version 4.0.0, Compix Inc. Imaging Systems,
Cranberry Township, PA).
Preparation of Target Plate with Hydrophobic Coating.
The target plates were spin-coated with a hydrophobic coating
using a modified centrifuge with a small hole in the top lid and a
custom-fitted Teflon rotor for the MALDI plates. During spinning
of the target plate at 1000 rpm, 500 µL of PFC 1601V coating
solution was slowly applied through the hole to the center of the
target plate. Subsequently, the target plate was spun for 1 min to
evenly distribute the coating solution. The coated plate was then
heated for 20 min at ∼200 °C. The coating material can also be
applied onto the target plate by simply using a brush, with a slight
compromise in coating homogeneity.
Quantitative Analysis. The following transitions were moni-
tored for SRM: lopinavir, 630.5 f 183 (collision energy, 30 eV);
ritonavir, 722 f 296 (30 eV); saquinavir, 671.5 f 570.5 (40 eV);
amprenavir, 506.5 f 245.5 (30 eV); indinavir, 614.5 f 421.5 (40
eV); nelfinavir, 569 f 331 (40 eV); tipranavir, 603.5 f 411 (30
eV); nevirapine, 267 f 226 (30 eV); carbamazepine, 237 f 194
(30 eV). As internal standard, carbamazepine for nevirapine,
Figure 5. SEM analysis of dried sample spots. Spot size reduction
for dispensed DHB solutions (25/75 acetonitrile/water): (a) 1 µL on
an uncoated stainless target; (b) 1 µL on a coated plate. The diameter
of the dried spot on the coated plate is ∼200 µm.
Figure 6. SRM traces of 4 pmol of indinavir (blue) and 1 pmol of
saquinavir (red) in a single spot using the novel matrix HFMC on a
stainless steel target plate (left) and on a fluoropolymer-coated target
plate (right).
Figure 7. Comparison of background signals in the full-scan mode
on uncoated and coated stainless steel (SS) plates (panel a). Panel
b shows the further improvements by heat curing the coated plates
for 20 min at 200 °C.
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indinavir for amprenavir, lopinavir for tipranavir, indinavir for
nelfinavir, saquinavir for ritonavir, nelfinavir for indinavir, and
tipranavir for lopinavir were used.
Two data sets, A and B, were measured, each containing five
replicate spots per analyte. Data set A was used to construct the
calibration curve while data set B served as quality control, and
vice versa. For each spot, the peak area ratios of analyte to internal
standard were measured. Subsequently, the average analyte/
internal standard ratios for the replicate analyses were calculated,
and used for the calibration curves and for quality control
purposes. Linear 1/x-weighed curves were used for calibration,
unless otherwise stated.
RESULTS AND DISCUSSION
In MALDI experiments, the nature of the matrix compound
has a crucial influence on the ionization efficiencies and the signal
intensities of the analytes of interest.28 For example, DHB and
HCCA are commonly used for analysis of peptides and small
proteins, while SA is preferred for larger proteins. When a small
molecule is used as matrix, many of the abundant peaks observed
in the low-mass range of the MALDI mass spectrum arise from
the matrix itself. Upon laser irradiation, matrix molecules undergo
a variety of different processes such as ionization and subsequent
fragmentation, photodissociation, and ion-molecule reactions,
leading to matrix-derived chemical noise in the low-m/z range.
These interfering signals seriously hamper the analysis of small
molecules with m/z values below 1000. Various approaches have
been described to overcome this limitation, for example, by
carefully choosing the matrix-to-analyte ratio,4 the use of addi-
tives,5 ionic liquids,6 or inorganic matrixes.7,8 The use of high
molecular weight porphyrin matrixes can also decrease the matrix-
derived chemical noise in the low-m/z range.10,11,29 We have
previously shown that using the high molecular weight porphyrin
matrix meso-tetrakis(pentafluorophenyl)porphyrin (F20TPP) re-
sults in a significant decrease of the matrix-related peaks in the
low-m/z range in MALDI-TOF analyses and that this matrix can
be used for quantitative analysis of HIV-1 protease inhibitors in
cell lysates.12,13 By contrast, in MALDI-FTICR mass spectrometry,
the high molecular weight matrix F20TPP undergoes extensive
dissociation on the time scale of the FTICR experiment (∼1 s)
and intense fragment ions are observed in the low mass range,
which leads to interfering chemical noise. Significantly less
fragmentation of such ions is observed in MALDI-TOF mass
spectrometers (10-4 s). Thus, for the quantitative analysis of small
molecules, a high molecular weight matrix was used for TOF
analyses and a low molecular weight matrix for the FTICR
experiments, showing that the type of mass analyzer can have a
significant influence on the choice of matrix for small-molecule
analysis by MALDI. Another efficient way for eliminating the
chemical noise is the application of MS/MS, by monitoring only
analyte-specific ion transitions. This technique is particularly useful
when a triple quadrupole MS is used for MS/MS. In the SRM
mode of the QqQ instrument, a nearly 100% duty cycle is obtained,
and this makes it extremely efficient for small molecule target
analysis. Using this technique, a wide variety of matrixes, such
as HCCA and DHB, have been used for small-molecule analysis.
Sleno and Volmer compared HCCA, DHB, and SA for analysis of
spirolide toxins, quinidine, danofloxacin, ramipril, and nadolol and
found that HCCA yielded the strongest signal intensities and the
best precision for these drugs.26,27 In addition, Gobey et al. showed
that HCCA resulted in successful detection of 175 out of the 208
tested compounds.22
Comparison of Matrixes. In the present study, we have
compared the use of the HCCA, DHB, SA, 3-hydroxypicolinic acid
(HPA), and a new matrix, 7-hydroxy-4-(trifluoromethyl)coumarin
(HFMC), for the analysis of seven HIV-1 protease inhibitors by
(28) Gross, J. H. In Mass Spectrometry: A Textbook, 1st ed.; Gross, J. H., Ed.;
Springer: New York, 2004.
(29) Ayorinde, F. O.; Hambright, P.; Porter, T. N.; Keith, Q. L., Jr. Rapid
Commun. Mass Spectrom. 1999, 13, 2474–2479.
Figure 8. Quantitative analysis of indinavir in PBMC lysates using the novel matrix HFMC on a stainless steel target plate and on a fluoropolymer-
coated plate.
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MALDI-QqQ (Figure 1). SA and HPA yielded very poor signal
intensities in comparison to HCCA, DHB, and HFMC. HCCA
exhibited intense signals only for nelfinavir, indinavir, and
saquinavir, but relatively weak signals for lopinavir, ritonavir,
amprenavir, and tipranavir. DHB and the new matrix HFMC on
the other hand generated very strong signals for all seven protease
inhibitors tested. Using MALDI-TOF and MALDI-FTICR, we have
previously shown that abundant signals for antiretroviral drugs
can be obtained by using a cationization approach with alkali
halides.12,13 Using MS/MS on the MALDI-QqQ instrument,
however, we found that the cationized drugs showed poor
fragmentation efficiencies and thus low SRM sensitivities com-
pared to the protonated precursor molecules. In general, we found
that higher collision energies were needed for fragmentation of
the cationized drugs as compared to the protonated forms.
Quantitative Analysis of Antiretroviral Drugs in Cell
Lysates using DHB Matrix. We explored DHB as matrix for
quantitative analysis of the protonated forms of the HIV protease
inhibitors nelfinavir, saquinavir, indinavir, lopinavir, and ritonavir
and the non-nucleoside reverse transcriptase inhibitor nevirapine
in lysates of PBMC (Table 1). The measurement precisions were
relatively high compared to LC-MS/MS methods for antiretro-
viral drugs in PBMC lysates.30 Sleno and Volmer showed that
using HCCA resulted in significantly better precisions as com-
pared to DHB, because of the more homogeneous crystal layers
formed from HCCA solutions.26,27 In our experiments, however,
the signal intensities for antiretroviral drugs were much better
for DHB as matrix as compared to HCCA (vide supra), neces-
sitating DHB as matrix. Unfortunately, no stable isotope standards
were commercially available for the analytes investigated here,
to compensate for the heterogeneous crystallization. Alternatively,
we used chemically similar protease inhibitors as internal standard
for analysis of the protease inhibitors of interest (see Experimental
Section) and carbamazepine as a chemically related internal
standard for the non-nucleoside reverse transcriptase inhibitor
nevirapine. Applying stable isotope standards generally results in
significantly better precisions, since the chemical properties of
internal standard and analyte are virtually identical. This is
particularly important for MALDI, as well-matched analyte and
internal standard pairs result in homogeneous cocrystallizations,
as recently shown by Sleno and Volmer.25 It was also shown in
that study, however, that structural analogues of the analyte could
be successfully used, as long as important solution-phase proper-
ties were appropriately matched. To compensate for the relatively
high fluctuations mentioned above, we measured and averaged
five replicates of each sample and used the mean analyte-to-
internal standard ratio to calculate the concentration in the sample.
The resulting average relative errors ranged between 5.0% for
indinavir to 8.3% for ritonavir. The lower limits of quantitation,
expressed as amount of drug per spot on the target plate, was 64
fmol for nelfinavir, 4 fmol for indinavir, 16 fmol for saquinavir, 64
fmol for lopinavir, 64 fmol for ritonavir, and 16 fmol for nevirapine.
These numbers readily allow the clinical application of the
technique.
Coumarin Matrix and Fluoropolymer-Coated Target Plates.
We also explored the use of the new matrix compound HFMC
(Figure 2) for quantitative analysis of indinavir in PBMC lysates.
HFMC is a photoluminescent molecule with a molecular mass of
230.02 Da. HFMC exhibits maximum light absorption at 355 nm,
which ideally matches the wavelength of the frequency-tripled,
solid-state Nd:YAG laser of the MALDI-QqQ system (λ ) 355 nm).
Upon excitation, HFMC emits fluorescent light at λ ) 498 nm. In
acidic solutions, HFMC is colorless, while it is bright yellow in
basic solutions. When the HFMC matrix was spotted on a stainless
steel target plate using the dried droplet technique, the quantita-
tive precisions and quantitative accuracies were poor. Inspection
of the SRM traces showed differential incorporation of analyte and
internal standard in the HFMC crystals. A fast evaporation
approach,15 i.e., spotting from 100% organic solvents, was used to
obtain a more homogeneous distribution of analyte and internal
standard in the HFMC crystals. However, extensive spreading of
the sample was observed when the fast evaporation protocol was
applied in combination with stainless steel target plates. It has
been previously shown that hydrophobic coatings can significantly
improve crystallization behavior on MALDI plates.31–35 In this
study, we coated the target plate with an inexpensive strongly
hydrophobic fluoropolymer (∼US $0.20/plate). The coated target
plates allowed spotting of large volumes of sample, even for 100%
organic solutions of up to 10 µL (Figure 3). Furthermore, even
these large volumes of sample dried to very small crystal areas
on the target plates, due to the remarkable focusing abilities of
the coating material (Figure 4). The reduction factor in the area
of the crystal layers was further investigated by spotting droplets
of 1-µL DHB solutions in acetonitrile/water mixtures of varying
composition on coated as well as uncoated target plates (Figure
5). Using the coated target plates, the area of the dried spots
reduced by a factor 18.2 (acetonitrile content of 75%), 23.3 (50%
ACN), and 31.5 (25% ACN), which is significantly larger than
previously reported coating materials.31–35 Figure 6 illustrates that
the coated target plates significantly improve the cocrystallization
of analyte and internal standard for indinavir when HFMC is used
as matrix. In addition, the measurement times for one spot were
reduced from 6 to 2.5 s. Another feature of the coating is a
significant reduction in background signals from contaminants
on the target plate (Figure 7). Figure 8 illustrates the improvement
in the concentration-response curve for indinavir in PBMC
lysates as well as improvement in precision when the fluoropoly-
mer-coated plate was used in combination with the HFMC matrix.
Using the fluoropolymer-coated plate, the average precision
improved from 34 (sd 17.6) to 9.9% CV (sd 5.7) and the relative
error went down from 10.1 (sd 4.8) to 4.6% (sd 3.6). In addition,
the lower limit of quantitation improved from 16 to 1 fmol per
spot on the target plate using a 1/x2-weighed linear curve.
CONCLUSIONS
There is an increasing interest in the use of MALDI mass
spectrometry for quantitative analysis of small molecules, due to
(30) Colombo, S.; Beguin, A.; Telenti, A.; Biollaz, J.; Buclin, T.; Rochat, B.;
Decosterd, L. A. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2005,
819, 259–276.
(31) Owen, S. J.; Meier, F. S.; Brombacher, S.; Volmer, D. A. Rapid Commun.
Mass Spectrom. 2003, 17, 2439–2449.
(32) Gundry, R. L.; Edward, R.; Kole, T. P.; Sutton, C.; Cotter, R. J. Anal. Chem.
2005, 77, 6609–6617.
(33) Konig, S.; Grote, J. Biotechniques 2002, 32, 912914-915.
(34) Redeby, T.; Roeraade, J.; Emmer, A. Rapid Commun. Mass Spectrom. 2004,
18, 1161–1166.
(35) Xiong, S.; Ding, Q.; Zhao, Z.; Chen, W.; Wang, G.; Liu, S. Proteomics 2003,
3, 265–272.
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its very high sample throughput capability, its insensitivity to ion
suppression, and the possibility of storing samples on target plates
for future use or reanalysis. Using a prototype MALDI-QqQ mass
spectrometer, we have shown here that this technique can be used
for accurate quantitative analysis of HIV protease inhibitors and
a non-nucleoside reverse transcriptase inhibitor in lysates of 1
million peripheral blood mononuclear cells. The limits of quan-
titation readily allows clinical applications of the technique. In this
study, we had to resort to chemical analogues as internal
standards, because stable isotope internal standards were not
available. Stable isotopes are often very expensive and are
frequently not commercially available, and the custom synthesis
of these compounds is laborious. While using chemical analogues
as internal standards may not at first appear to be the best choice,
it is frequently the only practical option for quantitative analysis
using LC-MS or MALDI-MS. In our study, we demonstrated that
chemically similar compounds as standards and replicate analyses
yielded excellent precision and accuracy. We have also shown
that the optimum matrix for specific analytes can be highly
compound dependent. By using a novel matrix and a fluoropoly-
mer surface coating, we were able to achieve improved cocrys-
tallization of analyte and internal standard, thus further improving
precisions and accuracies.
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